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Abstract 
Objective: Platelets may well be significant in the pathogenesis of cerebral infarction. Platelets vary substantially 
according to gender. The scope of our current work is to establish if female and male stroke sufferers differ regarding 
platelet reactivity.
Patients and methods: 73 Consecutive individuals stricken by acute ischemic cerebral infarction (31 females, 42 
males) participated. All stroke subtypes were included. Platelet counts was determined electronically. Platelet reac‑
tivity i.e. the presence of surface‑bound fibrinogen following provocation was analyzed with a flow cytometer. ADP 
(1.7 μmol/L) and a thrombin receptor agonist (TRAP‑6) (57 μmol/L) were the agonists used.
Results: Female stroke sufferers had higher platelet counts (p = 0.013) but their platelets were less reactive. The p 
values were (p = 0.038) and (p = 0.016) for ADP and TRAP‑6, respectively.
Conclusion: The current study demonstrates that women suffering acute cerebral infarction have less reactive plate‑
lets. It is concluded that gender affects platelets. Our study indicates that it may be beneficial to individualize platelet 
inhibition of stroke sufferers according to gender.
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Background
Drugs that suppress platelets e.g. aspirin, are benefi-
cial for preventing stroke recurrence [1]. Some workers 
have associated acute cerebral infarctions with increased 
platelet reactivity [2]. In contrast, recent work have found 
either lower platelet reactivity [3] or no reactivity altera-
tions [4]. Research into platelet activity in the event of 
acute stroke has also produced disparate findings. Sev-
eral researchers found increased platelet activity [5, 6] 
whereas recent work has revealed reduced activation 
[3, 4]. Platelets display substantial gender differences; 
women have increased platelet counts [7, 8] and female 
platelets display increased sensitivity to aggregating 
agents both before [8, 9] and after [7, 10] the menopause. 
The diversities encouraged us to undertake the current 
work which evaluates stroke victims with respect to gen-
der differences in platelet behavior.
Methods
Study subjects
We enrolled individuals (n =  73) stricken by acute cer-
ebral infarction admitted to a specialized stroke unit. 
The condition was defined as an abrupt loss of neuro-
logical functions exceeding 24 h. Brain hemorrhage cases 
and unconscious patients were excluded. Otherwise, no 
exclusion criteria were applied. We divided the disease 
into subtypes; viz. cardioembolism (n = 14), small artery 
disease (n = 38) and major stroke (n = 21). Subsequently, 
the subjects were divided according to gender (31 
women, 42 men) (Table  1). The study was approved by 
the Regional Ethical Review Board (Linköping, Sweden).
Analytical procedures
Determinations of surface-bound fibrinogen and mem-
brane-attached P-selectin were carried out in citrate 
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anticoagulated whole blood with a Beckman Coulter 
EPICS XL-MCL™ Flow Cytometer (Beckman Coul-
ter, Inc., Brea, Cal, USA). Earlier communications have 
described the laboratory procedures in detail [4, 7, 11]. 
An antibody against glycoprotein Ib (Dako AS, Glostrup, 
Denmark) detected platelets. Chicken antihuman fibrino-
gen polyclonal antibody (Biopool AB, Umeå, Sweden) 
identified surface-bound fibrinogen. An IgG1 (mouse) 
monoclonal antibody identified platelet bound P-selectin 
(Immunotech, France). The values of a negative control 
were subtracted from the experimental ones. The con-
trol contained EDTA to prevent platelet antibody bind-
ing. When determining platelet reactivity, ADP (1.7 and 
8.5  μmol/L) (Sigma-Aldrich, St Louis, MO, USA) and a 
thrombin receptor-activating peptide-6 (TRAP-6) (57 and 
74 μmol/L) (Biotechnology Centre of Oslo, Norway) were 
used as agonists. Platelet-bound P-selectin without ago-
nist provocation served as an estimate of platelet activity 
in  vivo [4, 11]. Soluble P-selectin and myeloperoxidase 
were used as markers of platelet/endothelial [11, 12] and 
neutrophil activity [13], respectively. ELISA kits (R&D 
system, Abingdon, GB) were employed for both determi-
nations. To avoid platelet in vitro activity, a blocking solu-
tion was used as an anticoagulant [4, 14]. High sensitive 
C-reactive protein (hsCRP) was determined using a tur-
biometric technique. Student’s t test and the Chi square 
test were employed for the statistical evaluations.
Results
Demographic data
Female stroke sufferers were older than their male coun-
terparts (Table 1). As expected female body weights were 
lower. At hospital admittance neither stroke subtypes nor 
concomitant diseases differed significantly with respect 
to gender. With one exception (ACE-inhibitors) the study 
groups had similar drug prescriptions.
Platelet reactivity and activity
At the acute stroke, female participants had increased 
platelet counts (Table  2) and their platelet distribution 
width was narrower. Platelet reactivity as estimated from 
platelet fibrinogen binding following agonist stimula-
tion varied such that females had less reactive platelets. 
Provocation with more concentrated ADP and TRAP-6 
also revealed a tendency towards lower platelet reactivity 
in females though the differences failed to reach statisti-
cal significance (Table 2). Platelet reactivity, as estimated 
from membrane-bound P-selectin after TRAP-6 
stimulation, proved to be unrelated to gender. Finally, 
platelet activity, as estimated from surface-attached 
P-selectin without agonist provocation and from circu-
lating P-selectin, was not associated with sexual category 
(Table 2).
Inflammatory response and erythrocytes
Females displayed augmented inflammatory response 
judging from neutrophil counts (Table  3). At the acute 
stroke, their neutrophils showed increased activity as 
estimated from plasma myeloperoxidase. In contrast, 
hsCRP showed no gender differences. Female stroke 
sufferers then had lower hemoglobin concentrations 
and increased red cell distribution width whereas their 
erythrocyte counts were similar to those of male controls 
(Table 3).
Discussion
This work has revealed gender differences concurrent 
with acute stroke. Female stroke sufferers displayed less 
platelet reactivity (Table  2). We further confirm earlier 
findings [7] in showing that females had higher platelet 
counts. Finally, at the acute stroke women had enhanced 
neutrophil counts. These cells circulate more activated 
in females based on plasma myeloperoxidase values 
(Table 3).
We found that platelets of women stroke patients 
responded less to agonist (Table  2). Previous work 
showed increased female platelet reactivity concurrent 
Table 1 Demographic data at  hospital admission for   
females and males with acute cerebral infarctions
NS not significant.
a mean ± SD.
Females Males p value
Subjects (n) 31 42
Age (years)a 78 ± 9 71 ± 9 0.001
Body weight (kg)a 70 ± 16 83 ± 13 0.004
Sampling time after the acute  
stroke (days)a
2.4 ± 1.6 2.0 ± 1.3 NS
Cardiogenic stroke (n) 8 6 NS
Small artery disease (n) 14 24 NS
Large artery disease (n) 9 12 NS
Recurrent stroke (n) 6 15 NS
Current smokers (n) 3 7 NS
Diabetes (n) 2 9 NS
Hypertension (n) 11 21 NS
Previous myocardial infarction (n) 2 5 NS
A2‑Blockers (n) 1 3 NS
ACE‑inhibitors (n) 13 4 0.001
Aspirin 75 mg (n) 11 19 NS
β‑Blockers (n) 10 11 NS
Ca2+‑Blockers (n) 6 9 NS
Clopidogrel (n) 0 0 NS
Diuretics (n) 5 9 NS
Statins (n) 4 11 NS
Vitamin K antagonists (n) 1 5 NS
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with coronary heart disease [7]. Furthermore, women 
with atherosclerosis have increased reactivity [10]. Sev-
eral researchers describe how platelets of stroke sufferers 
are less reactive than in suitable control groups [3, 4]. It 
is difficult to decide why coronary heart disease platelets 
differ from platelet behavior in conjunction with cerebral 
infarction. One can hypothesize that stroke and coronary 
heart disease have differing pathologies making platelets 
react differently.
Stroke incidence is lower in women and they are on 
average older than males at their first cerebral infarction 
[15–17]. Female stroke patients have higher prevalence 
of hypertension and cardioembolic stroke whereas dia-
betes and lacunar stroke are less frequent [17]. It agrees 
to a certain extent with this study. In our hands, how-
ever, probably due to the small sample size, the differ-
ences failed to reach significance (Table 1). Demographic 
and clinical characteristics differed further as women 
weighted less and more frequently had ACE-inhibi-
tors (Table  1). In particular, differences with respect to 
ongoing prescriptions could affect platelets and inflam-
matory reactions. The time point of blood sampling var-
ied substantially but did not differ significantly between 
groups (Table 1). It constitutes an uncertainty as the cur-
rent activity measures could rapidly change after an acute 
cerebral infarction. Female patients were older at hospital 
admission constituting a possible confounder. However, 
in our hands platelets and neutrophils do not demon-
strate any significant dependence on age (unpublished 
data). In everyday clinical practice it is practically impos-
sible to divide stroke events into subcategories. Previ-
ously, we were unable to see that stroke subtypes differ 
with respect to platelets and the inflammatory response 
[4]. Therefore, in this study all patients were evaluated 
together.
Lower platelet reactivity could be one of many rea-
sons as to why women on average get their first cerebral 
infarction later in life. Female stroke sufferers have higher 
1-month case fatality than men [15]. Age and disease 
severity may be possible reasons for the dissimilarities 
Table 2 Platelet reactivity and activity of female and male stroke sufferers
NS not significant, % percentage positive cells (either fibrinogen or P-selectin), TRAP-6 thrombin receptor activating peptide.
Females (mean ± SD)  
(n = 31)
Males (mean ± SD)  
(n = 42)
p value
Platelet counts (×109/L) 295 ± 105 245 ± 58 0.013
Platelet distribution width (%) 15.7 ± 1.7 16.4 ± 0.9 0.03
Platelet‑bound fibrinogen after agonist provocation
 ADP (1.7 μmol/L) (%) 23 ± 16 32 ± 17 0.038
 ADP (8.5 μmol/L) (%) 54 ± 21 62 ± 19 NS
 TRAP‑6 (57 μmol/L) (%) 35 ± 23 52 ± 29 0.016
 TRAP‑6 (74 μmol/L) (%) 51 ± 24 63 ± 22 NS
Platelet‑bound P‑selectin after agonist provocation
 TRAP‑6 (57 μmol/L) (%) 20 ± 13 15 ± 7 NS
 TRAP‑6 (74 μmol/L) (%) 41 ± 22 44 ± 18 NS
Platelet‑bound P‑selectin
 Without agonist (%) 4 ± 2 4 ± 1 NS
Soluble P‑selectin (μg/L) 70 ± 37 82 ± 47 NS
Table 3 The inflammatory response and red cell parameters for female and male patients with acute cerebral infarctions
NS not significant.
Females (mean ± SD)  
(n = 31)
Males (mean ± SD)  
(n = 42)
p value
High sensitive C‑reactive protein (g/L) 17 ± 18 9 ± 17 NS
Neutrophil counts (×1012/L) 5.6 ± 1.7 4.6 ± 1.6 0.011
Myeloperoxidase (μg/L) 16 ± 13 7 ± 6 0.006
Hemoglobin (g/L) 141 ± 13 149 ± 13 0.019
Red cell counts (×109/L) 4.6 ± 0.5 4.8 ± 0.5 NS
Red cell distribution width (%) 13.2 ± 1.4 12.4 ± 0.9 0.007
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[16, 17]. The inflammatory response has substantial 
impact upon long term survival after coronary heart dis-
ease [18]. It is to evaluate if inflammatory parameters 
may have prognostic influence after an acute cerebral 
infarction as well.
Conclusion
The current study indicates that subsequent work is nec-
essary to evaluate if platelet inhibition after acute stroke 
should be individualized according to gender. At present 
new powerful platelet inhibitory drugs are introduced. 
This work suggests that clinical trials are necessary before 
using these new drugs in particular in female stroke 
sufferers.
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